Clinical trial
Predicting the Presence and Severity of Coronary Artery Disease Using Surrogate Markers of Insulin Resistance: A Cross-Sectional Study
NCT06237244 is registered in ClinicalTrials.gov with Shiraz University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Predicting the Presence and Severity of Coronary Artery Disease Using Surrogate Markers of Insulin Resistance: A Cross-Sectional Study
- Lead sponsor
- Shiraz University of Medical Sciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 1, 2018
- Completion date
- September 1, 2023
- Enrollment
- 1,017 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.